Kiniksa Pharmaceuticals International Plc (KNSA)
45.61
+0.46
(+1.02%)
USD |
NASDAQ |
Mar 19, 16:00
45.61
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Profit Margin (Quarterly) : 7.02% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -162.1% |
| NovoCure Ltd. | -14.05% |
| LivaNova Plc | 8.56% |
| Aurinia Pharmaceuticals, Inc. | -- |
| Alterola Biotech, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 11.83% |
| Return on Assets | 8.89% |
| Return on Invested Capital | 11.60% |
| Gross Profit Margin (Quarterly) | 54.93% |
| Operating Margin (Quarterly) | 9.78% |
| Return on Net Operating Assets | 57.89% |